Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision entry now shows Revision: v3.6.5 as the latest update, replacing the previous v3.6.4. This reflects a small update to the page metadata rather than a substantive change to the study record.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.6.4 was added to the study’s history, while the previous revision v3.6.3 was removed. This reflects an update to the page’s version in the history log.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry (v3.6.3) has been added to the study history, and the previous revision (v3.6.2) has been removed. This represents an update to the record's version history.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.6.2 to the study record history, reflecting a software update to the page's revision tracking. This update marks the latest version label in the history table.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study record now indicates that the trial is no longer looking for participants, signaling that enrollment has been halted. This update also accompanies a revision label of v3.6.0, replacing the prior v3.5.5.SummaryDifference0.7%

- Check76 days agoChange DetectedThe record history shows a new latest revision labeled v3.5.5, superseding the previous v3.5.4, reflecting an update to the page's historical metadata.SummaryDifference0.1%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.